Reviewed,
UniProtKB/Swiss-Prot P12814 (ACTN1_HUMAN)
Last modified
September 2, 2008.
Version 112.
History...
Clusters with 100%,
90%,
50% identity |
Documents (5) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Alpha-actinin-1 Alternative name(s): Alpha-actinin cytoskeletal isoform Non-muscle alpha-actinin-1 F-actin cross-linking protein | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 892 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | F-actin cross-linking protein which is thought to anchor actin to a variety of intracellular structures. This is a bundling protein. |
| Subunit structure | Homodimer; antiparallel. Interacts with MYOZ2, PDLIM2 and TTID and LPP. |
| Subcellular location | Cytoplasm › cytoskeleton. Cytoplasm › myofibril › sarcomere › Z-disk. Note= Colocalizes with MYOZ2 and PPP3CA at the Z-line of heart and skeletal muscle. |
| Sequence similarities | Belongs to the alpha-actinin family. Contains 1 actin-binding domain. Contains 2 CH (calponin-homology) domains. Contains 2 EF-hand domains. Contains 4 spectrin repeats. |
Ontologies
Keywords | |
|---|---|
| Cellular component | Cytoplasm Cytoskeleton |
| Domain | Repeat |
| Ligand | Actin-binding Calcium |
| PTM | Phosphoprotein |
| Technical term | 3D-structure Direct protein sequencing |
Gene Ontology (GO) | |
| Biological process | focal adhesion formation Inferred from mutant phenotype. Source: UniProtKB negative regulation of cell motionInferred from mutant phenotype. Source: UniProtKB regulation of apoptosisNon-traceable author statement. Source: UniProtKB |
| Cellular component | focal adhesion Inferred from mutant phenotype. Source: UniProtKB pseudopodiumTraceable author statement. Source: UniProtKB |
| Molecular function | integrin binding Inferred from direct assay. Source: UniProtKB vinculin bindingInferred from physical interaction. Source: UniProtKB |
| Complete GO annotation... | |
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| PTPN1 | P18031 | 1 | EBI-351710,EBI-968788 | |
| SRC | P12931 | 2 | EBI-351710,EBI-621482 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | ||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 892 | 892 | Alpha-actinin-1 | |||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||
| Domain | 1 – 247 | 247 | Actin-binding | |||||||||||||||||||||||||||||||||||||
| Domain | 31 – 135 | 105 | CH 1 | |||||||||||||||||||||||||||||||||||||
| Domain | 144 – 247 | 104 | CH 2 | |||||||||||||||||||||||||||||||||||||
| Repeat | 274 – 384 | 111 | Spectrin 1 | |||||||||||||||||||||||||||||||||||||
| Repeat | 394 – 499 | 106 | Spectrin 2 | |||||||||||||||||||||||||||||||||||||
| Repeat | 509 – 620 | 112 | Spectrin 3 | |||||||||||||||||||||||||||||||||||||
| Repeat | 630 – 733 | 104 | Spectrin 4 | |||||||||||||||||||||||||||||||||||||
| Domain | 746 – 781 | 36 | EF-hand 1 | |||||||||||||||||||||||||||||||||||||
| Domain | 787 – 822 | 36 | EF-hand 2 | |||||||||||||||||||||||||||||||||||||
| Calcium binding | 759 – 770 | 12 | Potential | |||||||||||||||||||||||||||||||||||||
| Calcium binding | 800 – 811 | 12 | Potential | |||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||
| Modified residue | 12 | 1 | Phosphotyrosine; by FAK1 | |||||||||||||||||||||||||||||||||||||
| Modified residue | 50 | 1 | Phosphothreonine | |||||||||||||||||||||||||||||||||||||
| Modified residue | 140 | 1 | Phosphoserine | |||||||||||||||||||||||||||||||||||||
| Modified residue | 193 | 1 | Phosphotyrosine | |||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 317 | 1 | R → L in CAA38970. Ref.5 | |||||||||||||||||||||||||||||||||||||
| Sequence conflict | 477 | 1 | Q → L in CAA38970. Ref.5 | |||||||||||||||||||||||||||||||||||||
| Sequence conflict | 630 – 631 | 2 | RL → SV in CAA33803. Ref.1 | |||||||||||||||||||||||||||||||||||||
| Sequence conflict | 654 – 656 | 3 | GRI → ARF in CAA38970. Ref.5 | |||||||||||||||||||||||||||||||||||||
| Sequence conflict | 674 | 1 | Y → D in CAA38970. Ref.5 | |||||||||||||||||||||||||||||||||||||
| Sequence conflict | 778 | 1 | L → S in CAA38970. Ref.5 | |||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||
| Helix | 30 – 45 | 16 | ||||||||||||||||||||||||||||||||||||||
| Helix | 46 – 48 | 3 | ||||||||||||||||||||||||||||||||||||||
| Turn | 55 – 61 | 7 | ||||||||||||||||||||||||||||||||||||||
| Helix | 63 – 73 | 11 | ||||||||||||||||||||||||||||||||||||||
| Helix | 86 – 102 | 17 | ||||||||||||||||||||||||||||||||||||||
| Helix | 112 – 116 | 5 | ||||||||||||||||||||||||||||||||||||||
| Helix | 120 – 135 | 16 | ||||||||||||||||||||||||||||||||||||||
| Turn | 136 – 138 | 3 | ||||||||||||||||||||||||||||||||||||||
| Helix | 146 – 158 | 13 | ||||||||||||||||||||||||||||||||||||||
| Beta strand | 168 – 170 | 3 | ||||||||||||||||||||||||||||||||||||||
| Helix | 171 – 173 | 3 | ||||||||||||||||||||||||||||||||||||||
| Helix | 177 – 186 | 10 | ||||||||||||||||||||||||||||||||||||||
| Helix | 188 – 190 | 3 | ||||||||||||||||||||||||||||||||||||||
| Helix | 193 – 195 | 3 | ||||||||||||||||||||||||||||||||||||||
| Helix | 201 – 215 | 15 | ||||||||||||||||||||||||||||||||||||||
| Helix | 224 – 229 | 6 | ||||||||||||||||||||||||||||||||||||||
| Beta strand | 230 – 232 | 3 | ||||||||||||||||||||||||||||||||||||||
| Helix | 235 – 249 | 15 | ||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The cDNA sequence of a human placental alpha-actinin." Millake D.B., Blanchard A.D., Patel B., Critchley D.R. Nucleic Acids Res. 17:6725-6725(1989) [PubMed: 2780298] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Placenta. |
| [2] | "Cloning and chromosomal localization of the human cytoskeletal alpha-actinin gene reveals linkage to the beta-spectrin gene." Youssoufian H., McAfee M., Kwiatkowski D.J. Am. J. Hum. Genet. 47:62-71(1990) [PubMed: 2349951] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [3] | "Cloning of human full-length CDSs in BD Creator(TM) system donor vector." Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A. Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Colon and Skin. |
| [5] | "Expression of human alpha-actinin in human hepatocellular carcinoma." Nishiyama M., Ozturk M., Frohlich M., Mafune K., Steele G. Jr., Wands J.R. Cancer Res. 50:6291-6294(1990) [PubMed: 2169343] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 297-892. |
| [6] | "Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides." Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R., Vandekerckhove J. Nat. Biotechnol. 21:566-569(2003) [PubMed: 12665801] [Abstract] Cited for: PROTEIN SEQUENCE OF 1-21. Tissue: Platelet. |
| [7] | "Identification of the 70kD heat shock cognate protein (Hsc70) and alpha-actinin-1 as novel phosphotyrosine-containing proteins in T lymphocytes." Egerton M., Moritz R.L., Druker B., Kelso A., Simpson R.J. Biochem. Biophys. Res. Commun. 224:666-674(1996) [PubMed: 8713105] [Abstract] Cited for: PROTEIN SEQUENCE OF 134-146. |
| [8] | "Identification of the cytoskeletal protein alpha-actinin as a platelet thrombospondin-binding protein." Dubernard V., Faucher D., Launay J.-M., Legrand C. FEBS Lett. 364:109-114(1995) [PubMed: 7750553] [Abstract] Cited for: PROTEIN SEQUENCE OF 566-577; 727-738 AND 835-863, SUBCELLULAR LOCATION. |
| [9] | "Myotilin, a novel sarcomeric protein with two Ig-like domains, is encoded by a candidate gene for limb-girdle muscular dystrophy." Salmikangas P., Mykkaenen O.M., Groenholm M., Heiska L., Kere J., Carpen O. Hum. Mol. Genet. 8:1329-1336(1999) [PubMed: 10369880] [Abstract] Cited for: INTERACTION WITH TTID. |
| [10] | "Calsarcins, a novel family of sarcomeric calcineurin-binding proteins." Frey N., Richardson J.A., Olson E.N. Proc. Natl. Acad. Sci. U.S.A. 97:14632-14637(2000) [PubMed: 11114196] [Abstract] Cited for: INTERACTION WITH MYOZ2. |
| [11] | "The cytoskeletal/non-muscle isoform of alpha-actinin is phosphorylated on its actin-binding domain by the focal adhesion kinase." Izaguirre G., Aguirre L., Hu Y.P., Lee H.Y., Schlaepfer D.D., Aneskievich B.J., Haimovich B. J. Biol. Chem. 276:28676-28685(2001) [PubMed: 11369769] [Abstract] Cited for: PHOSPHORYLATION AT TYR-12. |
| [12] | "The lipoma preferred partner LPP interacts with alpha-actinin." Li B., Zhuang L., Reinhard M., Trueb B. J. Cell Sci. 116:1359-1366(2003) [PubMed: 12615977] [Abstract] Cited for: INTERACTION WITH LPP. |
| [13] | "Global phosphoproteome analysis on human HepG2 hepatocytes using reversed-phase diagonal LC." Gevaert K., Staes A., Van Damme J., De Groot S., Hugelier K., Demol H., Martens L., Goethals M., Vandekerckhove J. Proteomics 5:3589-3599(2005) [PubMed: 16097034] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-50, MASS SPECTROMETRY. Tissue: Hepatocyte. |
| [14] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140, MASS SPECTROMETRY. Tissue: Epithelium. |
| [15] | "Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer." Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L., Mitchell J., Wetzel R., Macneill J., Ren J.M. Comb M.J.Cell 131:1190-1203(2007) [PubMed: 18083107] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-193, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| X15804 mRNA. Translation: CAA33803.1. M95178 mRNA. Translation: AAA51582.1. BT007207 mRNA. Translation: AAP35871.1. BC003576 mRNA. Translation: AAH03576.1. BC015766 mRNA. Translation: AAH15766.1. X55187 mRNA. Translation: CAA38970.1. | |||||||||||||||||||
| PIR | FAHUAA. S05503. | ||||||||||||||||||
| RefSeq | NP_001093.1. | ||||||||||||||||||
| UniGene | Hs.509765 | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| |||||||||||||||||||
| SMR | P12814. Positions 25-892. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| IntAct | P12814. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| PhosphoSite | P12814. | ||||||||||||||||||
2-D gel databases | |||||||||||||||||||
| OGP | P12814. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PeptideAtlas | P12814. | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENSG00000072110. Homo sapiens. [Contig view] | ||||||||||||||||||
| GeneID | 87. | ||||||||||||||||||
| KEGG | hsa:87. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| H-InvDB | HIX0011761. HIX0055478. | ||||||||||||||||||
| HGNC | HGNC:163. ACTN1. | ||||||||||||||||||
| HPA | CAB004303. HPA006035. | ||||||||||||||||||
| MIM | 102575. gene. | ||||||||||||||||||
| PharmGKB | PA24. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
| GeneCards | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| HOVERGEN | P12814. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | P12814. | ||||||||||||||||||
| CleanEx | HS_ACTN1. | ||||||||||||||||||
| GermOnline | ENSG00000072110. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| InterPro | IPR001589. Actinin_actin-bd_CS. IPR016146. Calponin-homology. IPR001715. Calponin_act_bd. IPR014837. EF-hand_Ca_insen. IPR011992. EF-Hand_type. IPR002048. EF_hand_Ca_bd. IPR002017. Spectrin_repeat. [Graphical view] | ||||||||||||||||||
| Gene3D | G3DSA:1.10.418.10. Calponin-homology. 2 hits. G3DSA:1.10.238.10. EF-Hand_type. 2 hits. | ||||||||||||||||||
| Pfam | PF00307. CH. 2 hits. PF00036. efhand. 2 hits. PF08726. efhand_Ca_insen. 1 hit. PF00435. Spectrin. 4 hits. [Graphical view] | ||||||||||||||||||
| ProDom | PD000012. EF-hand. 1 hit. [Graphical view] [Entries sharing at least one domain] | ||||||||||||||||||
| SMART | SM00033. CH. 2 hits. SM00054. EFh. 2 hits. SM00150. SPEC. 3 hits. [Graphical view] | ||||||||||||||||||
| PROSITE | PS00019. ACTININ_1. 1 hit. PS00020. ACTININ_2. 1 hit. PS50021. CH. 2 hits. PS00018. EF_HAND_1. 1 hit. PS50222. EF_HAND_2. 2 hits. [Graphical view] | ||||||||||||||||||
| BLOCKS | Search... | ||||||||||||||||||
Other Resources | |||||||||||||||||||
| LinkHub | P12814. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Entry information
| Entry name | ACTN1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P12814 Secondary accession number(s): Q9BTN1 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||

Clusters with